FDA Inspection 924507 — Novartis Pharma Stein AG

Novartis Pharma Stein AG — FEI 3002653483

The FDA completed an inspection of Novartis Pharma Stein AG on May 1, 2015 in Stein Ag. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 1, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Stein Ag (Switzerland)